Online registration is now closed, there will be a limited number of onsite registrations on Monday

The convergence between digital health and the life sciences is creating new opportunities to transform patient care as well as drug discovery and development. From wearables to machine learning, digital technologies are easing data collection from patients, increasing medical adherence, reshaping clinical trials, and offering new insights into real-world applications of therapies. Embedding digital health tools into the life sciences will also allow new therapies to better work within the growing value-based healthcare system that relies on data and measurable outcomes.

Join MassBio for our inaugural Digital Health Impact 2019 event at the InterContinental Boston at 510 Atlantic Ave, Boston, MA 02210, part of Biotech Week Boston, as we examine the current state of digital health as it relates to the life sciences, the challenges facing its growth, and opportunities for collaboration. Through keynotes, panel discussions, and case studies, we’ll explore new strategies for life sciences and digital health innovators to converge and ultimately deliver better outcomes for patients. Contact Laura Rudberg for sponsorship opportunities. View our sponsorship prospectus here

VP of Innovation, Anthem
Mariya Filipova leads Anthem’s Innovation function and oversees a network of ecosystem hubs across the country. She also leads a portfolio of initiatives that accelerate Anthem’s transformation into an AI-first company taking full advantage of exponential technologies and new business models. Mariya’s past experience as an entrepreneur and wall street analyst has shaped her perspective on transformation in closely regulated industries in Europe and the United States. She is a trusted advisor to both healthcare veterans and new entrants, from established industry leaders to start-ups in e-commerce, retail, and tech. Mariya previously led Deloitte’s global Future of Work Program Office, a portfolio of investments that use exponential technologies (e.g. blockchain, artificial intelligence) to redefine the way we do and monetize work.  She holds an MBA from Harvard Business School and a BA in Economics, summa cum laude, from Mount Holyoke College. She remains active in her alumni community where she serves on the Board of Governors for the Harvard Business School Association of Boston. She is currently based in Boston, MA.

Brought to you by